Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study

Impact of prior SARS-CoV-2 infection on incidence of hospitalization and adverse events following mRNA SARS-CoV-2 vaccination: A nationwide, retrospective cohort study

Background: Previous studies evaluated the SARS-CoV-2 vaccine safety or compared adverse events following vaccination to those from infection. Limited data about the impact of prior infection on post-vaccine adverse events are available. The objective of this study was to evaluate the impact of prio...

Full description

Bibliographic Details
Main Authors: Branch-Elliman, W. (Author), Do, N.V (Author), Fillmore, N.R (Author), La, J. (Author), Li, L.L (Author), Monach, P.A (Author), Strymish, J.M (Author), Zheng, C. (Author)
Format: Article
Language:English
Published: Elsevier Ltd 2022
Subjects:
adult
Adverse events
aged
Aged
Article
clinical trial
cohort analysis
comorbidity
controlled study
coronavirus disease 2019
Covid-19
COVID-19
COVID-19 Vaccines
drug safety
elasomeran
falling
female
fever
hospitalization
Hospitalization
human
Humans
incidence
Incidence
longitudinal study
major clinical study
male
medical history
medical record review
messenger RNA
microbiological examination
middle aged
mortality
mortality risk
mRNA vaccine
mRNA Vaccines
multicenter study
recombinant vaccine
Retrospective Studies
retrospective study
RNA vaccine
RNA, Messenger
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
side effect
Surveillance
tozinameran
Trigger tools
vaccination
Vaccination
Vaccines, Synthetic
veteran
weakness
Online Access:View Fulltext in Publisher

Internet

View Fulltext in Publisher

Similar Items